PNC Financial Services Group
DNA.WS

PNC Financial Services Group’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

PNC Financial Services Group’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200
Closed -$6 – 4956
2024
Q2 		$6 Hold
200
– – ﹤0.01% 4751
2024
Q1 		$18 Hold
200
– – ﹤0.01% 4674
2023
Q4 		$21 Hold
200
– – ﹤0.01% 4596
2023
Q3 		$45 Hold
200
– – ﹤0.01% 4581
2023
Q2 		$52 Hold
200
– – ﹤0.01% 4706
2023
Q1 		$36 Hold
200
– – ﹤0.01% 4648
2022
Q4 		$40 Hold
200
– – ﹤0.01% 4725
2022
Q3 		$0 Hold
200
– – ﹤0.01% 4652
2022
Q2 		$0 Hold
200
– – ﹤0.01% 4775
2022
Q1 		$0 Buy
+200
New +$223 ﹤0.01% 4744

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

PNC Financial Services Group's DNA.WS Position: Q3 2024 in Review

PNC Financial Services Group sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 200 shares — an estimated $6 sold.

PNC Financial Services Group first reported a position in DNA.WS in Q1 2022 and held it in 10 quarters. The position peaked at $52 in Q2 2023. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • PNC Financial Services Group reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 200 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $6.
  • PNC Financial Services Group first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q1 2022 and held it in 10 quarters.
  • PNC Financial Services Group's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $52 in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on PNC Financial Services Group's 13F filing for Q3 2024, filed 8 Nov 2024.